Standard Biotools (LAB) Capital Expenditures Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | -6.52% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -81.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -81.77% |
| Mar 31, 2026 | -93.69% |
| Dec 31, 2025 | 122.67% |
| Sep 30, 2025 | -100.97% |
| Jun 30, 2025 | -523.69% |
| Mar 31, 2025 | 547.12% |
| Dec 31, 2024 | -14.75% |
| Sep 30, 2024 | 449.50% |
| Jun 30, 2024 | -193.20% |
| Mar 31, 2024 | -22.67% |
| Dec 31, 2023 | -464.64% |
| Sep 30, 2023 | -28.40% |
| Jun 30, 2023 | -10.66% |
| Mar 31, 2023 | 16.36% |
| Dec 31, 2022 | 51.00% |
| Sep 30, 2022 | -90.13% |
| Jun 30, 2022 | -91.55% |
| Mar 31, 2022 | -87.46% |
| Dec 31, 2021 | -95.33% |
| Sep 30, 2021 | 3,676.11% |